BrightOwl Loader Loading

Intern: Global Process Analytical - United States  

Company managed [?] Still accepting applications
7 Facebook  Linkedin

Posted on : 11 April 2017

Project Description

External Posting TitleIntern: Global Process Analytical
Job DescriptionThis is a full-time internship opportunity from June - August 2017.

The Global Process Analytical (GPA) Intern position provides an exciting opportunity to gain hands-on experience and exposure to a Process Analytical global function. Working closely with the GPA team, the intern will support operations of several groups within GPA including but not limited to:

• Process Data Structuring

• Process Data Analysis

• Process Data Modeling

• Knowledge Management Tool Development

Key Responsibilities:

• Assist in the management and execution of GPA day-to-day operations

• Assist the GPA team with data structuring, visualization and basic statistical analysis

• Assess the team’s sharepoint space and propose a more visual environment

• Revise training material and suggest effective formats
LocationResearch Triangle Park, NC, US
Job CategoryManufacturing, Internship
Requisition Number31183BR
• Proficient with Microsoft Office, particularly with Excel and PowerPoint

• Understanding of Bio-Pharmaceutical production

• Ability to communicate in group settings

• Strong verbal and written skills

To participate in the Biogen Summer Intern Program, students must meet the following eligibility criteria:

• Legal authorization to work in the U.S.

• Enrollment in a full-time graduate program, returning to the academic program following Biogen internship assignment

• At least 18 years of age prior to the scheduled start date

• Understanding of Bio-pharmaceutical production

• Proficient with the use of Microsoft solutions, particularly with Excel and Power Point
• Graduate student who has completed at least one semester of the program

• Desired majors include: Science, engineering, computer sciences or mathematics
About BiogenCorporate Overview
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis (MS), has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Biogen also manufactures and commercializes biosimilars of advanced biologics. Our global organization of nearly 7,000 employees is committed to a single mission: making a meaningful difference in the lives of patients with few or no treatment options.
  • Biogen was founded in 1978 and today serves patients in nearly 70 countries.
  • A Fortune 500 company, Biogen in 2016 had revenues of $11.4 billion
  • Global headquarters in Cambridge, MA, and international headquarters in Zug, Switzerland
Our Science
We aspire to have the greatest impact on patients and science of any biotechnology company in the history of our industry. To us, that means creating novel medicines that benefit individuals and society, and bringing new scientific understanding to diseases for which there are no adequate treatments.
  • For nearly two decades Biogen has led in the research and development of new therapies to treat MS, including the most prescribed oral treatment in the world. Now our research is driving revolutionary new MS treatments with the goal of reversing or even repairing damage caused by the disease.
  • We are now applying our neurological expertise to solve some of most challenging and complex diseases of the brain, including Alzheimer’s disease, Parkinson’s disease, and ALS.
  • As we uncover new insights into human biology, Biogen is employing cutting-edge technologies to discover potential treatments for rare and genetic disorders.
  • Biogen is revolutionizing biologics manufacturing, developing the industry’s most advanced plants and processes. This expertise is used to produce both original innovative therapies and biosimilars that expand patient access to lower-cost medicines.
Our Corporate Citizenship
The same intellectual discipline and passion that drives our science is reflected in our corporate citizenship, environmental sustainability, and commitment to diversity and inclusion. As a company, we are focused on improving science education and limiting the impact of our company on the environment. In 2015, we became a carbon neutral company and ranked first place on Newsweek’s 2015 Green Rankings, and we are an industry leader on the Dow Jones Sustainability World Index. Biogen was named to Science’s list of Top Employers of 2015 and in 2017 received a perfect score of 100 for the fourth consecutive year on the Human Rights Campaign (HRC) Corporate Equality Index, which also named Biogen as one of its Best Places to Work.

All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.

Please be advised that all legitimate correspondence from a Biogen employee will come from "" email accounts.

Job Segment: Analytics, Biotech, Intern, Developer, Engineer, Management, Science, Entry Level, Technology, Engineering